BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Bonaccorsi G, Papini D, Bonanni P, Lo NA, Comodo N. Effects of a booster dose of tetanus toxoid after different primary courses of vaccination: implications
on the use of immune globulin. Ann Ig 2001; 13(1):3­10.
Bordet, A. L., Michenet, P., Cohen, C., Arbion, F., Ekindi, N., Bonneau, C., Kerdraon, R., and Coville, M. [Post­vaccination granuloma due to aluminium]
Ann.Pathol. 2001, 21 (2): 149­152.
Borrow, R., Goldblatt, D., Andrews, N., Richmond, P., Southern, J., and Miller, E. Influence of prior meningococcal c polysaccharide vaccination on the
response and generation of memory after meningococcal c conjugate vaccination in young children J.Infect.Dis. 8­1­2001, 184 (3): 377­380.
Borrow, R., Southern, J., Andrews, N., Peake, N., Rahim, R., Acuna, M., Martin, S., Miller, E., and Kaczmarski, E. Comparison of antibody kinetics following
meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccinenaive
controls Vaccine. 4­30­2001, 19 (23­24): 3043­3050.
Bos, J. M., Rumke, H. C., Welte, R., Postma, M. J., and Jager, J. C. Health economics of a hexavalent meningococcal outer­membrane vesicle vaccine in
children: potential impact of introduction in the Dutch vaccination program Vaccine. 10­12­2001, 20 (1­2): 202­207.
Boulianne, N., De Serres, G., Duval, B., Shadmani, R., and Rochette, L. Clinical manifestations and incidence of oculo­respiratory syndrome following
influenza vaccination­­Quebec, 2000 Can.Commun.Dis.Rep. 5­15­2001, 27 (10): 85­90.
Bradbury, J. USA to increase smallpox vaccine stockpile Lancet Infect.Dis. 2001, 1 (5): 290.
Brayden, R. and France, E. K. Efficient vaccination practices Pediatr.Ann. 2001, 30 (5): 284­288.
Brearley MJ. Vaccine­associated feline sarcomas. Vet Rec. 2001 May 5;148(18):580.
Breithaupt, T., Harris, K., Ellis, J., Purcell, E., Weir, J., Clothier, M., and Boesler, D. Thoracic lymphatic pumping and the efficacy of influenza vaccination in
healthy young and elderly populations J.Am.Osteopath.Assoc. 2001, 101 (1): 21­25.
Bretscher, P., Menon, J., Power, C., Uzonna, J., and Wei, G. A case for a neonatal, low­dose BCG vaccination trial Scand.J.Infect.Dis. 2001, 33 (4): 253­257.
Broker, M. Meningococcal vaccination for college freshmen Cleve.Clin.J.Med. 2001, 68 (10): 879.
Brouns, R., Verlinde, P., Lagae, L., De Koster, J., Lemmens, F., and Van de, Casseye W. Subacute sclerosing panencephalitis in a vaccinated, internationally
adopted child Acta Neurol.Belg. 2001, 101 (2): 128­130.
Brunton, D. Practitioners versus legislators: the shaping of the Scottish vaccination act Proc.R.Coll.Physicians Edinb. 1993, 23 (2): 193­201.
Brydak, L. B., Roszkowska­Blaim, M., Machala, M., Leszczy&nacute, ska, B., and Sieniawska, M.
Burkhard C, Choi M, Wilhelm H. Optic neuritis as a complication in preventive tetanus­diphtheria­poliomyelitis vaccination: a case report. Klin Monatsbl
Augenheilkd 2001 Jan;218(1):51­4.
Burton, A. Spain says good­bye to measles Lancet Infect.Dis. 2001, 1 (3): 142.
Buxton, J. A., Skowronski, D. M., Ng, H., Marion, S. A., Li, Y., King, A., and Hockin, J. Influenza revaccination of elderly travelers: antibody response to
single influenza vaccination and revaccination at 12 weeks J.Infect.Dis. 7­15­2001, 184 (2): 188­191.
Campos, J. Haemophilus influenzae: from the post­vaccination era to antibiotic resistance Clin.Microbiol.Infect. 2001, 7 (6): 287­290.
Ceyhan, M., Kanra, G., Erdem, G., and Kanra, B. Immunogenicity and efficacy of one dose measles­mumps­rubella (MMR) vaccine at twelve months of age
as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age Vaccine. 8­14­2001, 19 (31):
4473­4478.
Chee, C. B., Soh, C. H., Boudville, I. C., Chor, S. S., and Wang, Y. T. Interpretation of the Tuberculin Skin Test in Mycobacterium bovis BCG­vaccinated
Singaporean Schoolchildren Am.J.Respir.Crit Care Med. 9­15­2001, 164 (6): 958­961.
Cochi, S. L., Sutter, R. W., and Aylward, R. B. Possible global strategies for stopping polio vaccination and how they could be harmonized Dev.Biol.(Basel).
2001, 105:153­8; discussion 159. (): 153­158.
Cohen, J. Bioterrorism. Smallpox vaccinations: how much protection remains? Science. 11­2­2001, 294 (5544): 985.
Cohn, D. L. The Effect of BCG Vaccination on Tuberculin Skin Testing. Does it matter? Am.J.Respir.Crit Care Med. 9­15­2001, 164 (6): 915­916.
Conyn­Van Spaendonck MA M, de Melker HE H, Abbink F, Elzinga­Gholizadea N, Kimman TG, van Loon T T. Immunity to Poliomyelitis in the
Netherlands. Am J Epidemiol 2001 Feb 1;153(3):207­14
Cook, I. F. and Murtagh, J. Paediatric vaccination practice in a division of general practice Aust.Fam.Physician. 2001, 30 (12): 1185­1189.
Cook, I. Paediatric vaccination: the orange hub needle is acceptable Aust.Fam.Physician. 2001, 30 (4): 311­312.
Cookson, C. Benefit and risk of vaccination as seen by the general public and the media Vaccine. 10­15­2001, 20 Suppl 1:S85­8. (): S85­S88.
Courtney PA, Patterson RN, Lee RJ. Henoch­Schonlein purpura following meningitis C vaccination. Rheumatology (Oxford). 2001 Mar;40(3):345­6.
Courtney, P. A., Patterson, R. N., and Lee, R. J. Henoch­Schonlein purpura following meningitis C vaccination Rheumatology.(Oxford). 2001, 40 (3): 345­
346.
Cox, R. J., Mykkeltvedt, E., Sjursen, H., and Haaheim, L. R. The effect of zanamivir treatment on the early immune response to influenza vaccination
Vaccine. 9­14­2001, 19 (32): 4743­4749.
Crocetti, E., Arniani, S., Bordoni, F., Maciocco, G., Zappa, M., and Buiatti, E.
Cui, X. W., Nagao, M. M., and Effler, P. V. Influenza and pneumococcal vaccination coverage levels among Hawaii statewide long­term­care facilities
Infect.Control Hosp.Epidemiol. 2001, 22 (8): 519­521.
Cuthbert JA. Hepatitis A: Old and New. Clin Microbiol Rev 2001 Jan;14(1):38­58
Dagan, R., Amir, J., Ashkenazi, S., Hardt, K., and Kaufhold, A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of
immune memory after combined diphtheria­tetanus­pertussis­polio­Haemophilus influenzae type b primary vaccination Pediatr.Infect.Dis.J. 2001, 20 (6):
587­592.
Dalpke, A., Zimmermann, S., and Heeg, K. CpG­oligonucleotides in vaccination: signaling and mechanisms of action Immunobiology. 2001, 204 (5): 667­
676.
Danovaro­Holliday, M. C., Zimmerman, L., and Reef, S. E. Preventing Congenital Rubella Syndrome (CRS) through Vaccination of Susceptible Women of
Childbearing Age J.Womens Health Gend.Based.Med. 2001, 10 (7): 617­619.
Daum, R. S., Zenko, C. E., Given, G. Z., Ballanco, G. A., Parikh, H., and Germino, K. Magnitude of Interference after Diphtheria­Tetanus Toxoids­Acellular
Pertussis/Haemophilus influenzae Type b Capsular Polysaccharide­Tetanus Vaccination Is Related to the Number of Doses Administered J.Infect.Dis. 11­
15­2001, 184 (10): 1293­1299.
Davis, J. W., Lee, E., Taira, D. A., and Chung, R. S. Influenza vaccination, hospitalizations, and costs among members of a medicare managed care plan
Med.Care. 2001, 39 (12): 1273­1280.
Davis, R. L. and Bohlke, K. Measles Vaccination and Inflammatory Bowel Disease: Controversy Laid to Rest? Drug Saf 2001; 24(13): 939­946.
Davis, R. L., Lieu, T. A., Mell, L. K., Capra, A. M., Zavitkovsky, A., Quesenberry, C. P., Jr., Black, S. B., Shinefield, H. R., Thompson, R. S., and Rodewald,
L. E. Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations Pediatrics.
2001, 107 (4): 671­676.
Dayan, G. H., Nguyen, V. H., Debbag, R., Gomez, R., and Wood, S. C. Cost­effectiveness of influenza vaccination in high­risk children in Argentina Vaccine.
2001, %20;19 (30): 4204­4213.
De Kleijn, E., van Eijndhoven, L., Vermont, C., Kuipers, B., van Dijken, H., Rumke, H., de Groot, R., van Alphen, L., and van den, Dobbelsteen G. Serum
bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine
Vaccine. 11­12­2001, 20 (3­4): 352­358.
De Los Rios, Martin R., Garcia, Marin N., Sanz, Moreno J., and Ballester, Orcal E. [Mumps in an urban area of the Community of Madrid. Vaccination status,
diagnosis and intervention measures] Aten.Primaria. 6­15­2001, 28 (1): 10­16.